by 
Galaxy Diagnostics co-founder Dr. Edward B. Breitschwerdt, a research professor at the North Carolina State University (NCSU) College of Veterinary Medicine, earlier this week spoke with the NCSU news podcast Audio Abstract about Bartonella. The audio podcast and a transcript are available on the NCSU website.
This podcast serves as an educational resource for Bartonella species following publication of an important case study written by Dr. Breitschwerdt and other prominent researchers in the field.
During this conversation with podcast commentator, Tracey Peake, Dr. Breitschwerdt discusses:
- Why it is so difficult to detect Bartonella species with current laboratory testing methods
- Why accurate testing is important
- Ongoing global research efforts to determine where the bacteria may be when they are not found in the bloodstream
- The breadth of medical conditions that may be associated with Bartonella species infections (bartonellosis)
Cat scratch disease is a well-known manifestation of acute Bartonella henselae infection, but chronic non-specific symptoms are increasingly being linked to Bartonella species.
Visit our podcast links page to listen to this and other podcasts where Galaxy Diagnostics scientists discuss flea and tick-borne diseases including bartonellosis, Lyme borreliosis, and more.
About Galaxy Diagnostics, Inc.
As a social venture and a One Health company, Galaxy Diagnostics is passionate about protecting the animal-human bond through the surveillance, prevention and clinical management of flea- and tick-borne diseases shared by people and animals. Not only do we offer the best possible molecular and serology test options available, but we work with researchers and clinicians to generate new knowledge about emerging infectious diseases such as bartonellosis, Lyme borreliosis and other vector-borne diseases. Based on our scientific expertise, we are able to provide counsel to clinicians and researchers dedicated to achieving the most accurate diagnosis possible for their patients. Our mission is reflected in our corporate values, clinical service offerings, and everyday interaction with patients, clinicians and researchers.
Media contact: James Rebenski
contact@galaxydx.com
